ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.71
-0.56%
US Tech 100
18,377.20
0.82%
S&P 500
5,307.01
-0.27%
US Dollar vs CAD
1.36775
-0.10%
Bitcoin
69,741.61
0.92%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Theratechnologies Inc (THTX)

  7. Theratechnologies Inc (THTX) News

THTX

Theratechnologies (THTX)

Theratechnologies Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:THTX
DateTimeSourceHeadlineSymbolCompany
05/10/202412:10PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
05/09/20244:26PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
05/09/20243:30PMGlobeNewswire Inc.Theratechnologies Reports on its Annual Meeting of ShareholdersNASDAQ:THTXTheratechnologies Inc
05/02/20246:30AMGlobeNewswire Inc.Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (sudocetaxel zendusortide) in Solid Tumors at 2024 ASCO MeetingNASDAQ:THTXTheratechnologies Inc
04/15/20243:15PMGlobeNewswire Inc.Theratechnologies Announces Mailing of Management Proxy Circular in Connection with its Annual Meeting of ShareholdersNASDAQ:THTXTheratechnologies Inc
04/11/20246:30AMGlobeNewswire Inc.Theratechnologies to Present at the 2024 Bloom Burton & Co. Healthcare Investor ConferenceNASDAQ:THTXTheratechnologies Inc
04/10/20246:30AMGlobeNewswire Inc.Theratechnologies Reports Financial Results and Provides Business Update for First Quarter 2024NASDAQ:THTXTheratechnologies Inc
04/10/20246:15AMIH Market NewsU.S. Index Futures Show Mixed Trend Ahead of Key Inflation Data Release, Oil Prices Edge HigherNASDAQ:THTXTheratechnologies Inc
04/08/20243:30PMGlobeNewswire Inc.Theratechnologies Preclinical Data Presentation at AACR 2024 Highlights Versatility and Flexibility of SORT1+ Technology™ Oncology PlatformNASDAQ:THTXTheratechnologies Inc
04/05/202410:00AMGlobeNewswire Inc.Theratechnologies Appoints Elina Tea to its Board of DirectorsNASDAQ:THTXTheratechnologies Inc
04/03/20246:30AMGlobeNewswire Inc.Theratechnologies to Announce First Quarter 2024 Financial Results and Provide Business UpdateNASDAQ:THTXTheratechnologies Inc
03/28/20246:30AMGlobeNewswire Inc.Theratechnologies to Present Preclinical Data at AACR on Multiple PDCs Showcasing Potential of SORT1+Technology™ PlatformNASDAQ:THTXTheratechnologies Inc
03/22/20248:36AMGlobeNewswire Inc.Theratechnologies Announces Update on its Preclinical Oncology Research ProgramNASDAQ:THTXTheratechnologies Inc
03/21/20247:00PMGlobeNewswire Inc.Theratechnologies Appoints Jordan Zwick to its Board of DirectorsNASDAQ:THTXTheratechnologies Inc
03/21/20246:30AMGlobeNewswire Inc.Theratechnologies Initiates Increased Dose Level in Phase 1 Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian CancerNASDAQ:THTXTheratechnologies Inc
02/29/20243:55PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
02/29/20243:34PMGlobeNewswire Inc.Theratechnologies Announces the Resignation of One of Its Directors, Mr. Alain TrudeauNASDAQ:THTXTheratechnologies Inc
02/27/20247:37AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
02/27/20246:30AMGlobeNewswire Inc.Theratechnologies Receives Refusal to File Letter for Trogarzo® Intramuscular Method of Administration sBLA from FDANASDAQ:THTXTheratechnologies Inc
02/21/20247:01AMEdgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:THTXTheratechnologies Inc
02/21/20247:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
02/21/20246:30AMGlobeNewswire Inc.Theratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2023 and Provides 2024 GuidanceNASDAQ:THTXTheratechnologies Inc
02/20/20246:30AMGlobeNewswire Inc.Theratechnologies Announces Publication in Frontiers in Immunology that Deepens Understanding of Sudocetaxel Zendusortide (TH1902) Molecular Mechanism of ActionNASDAQ:THTXTheratechnologies Inc
02/15/20247:36AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
02/15/20246:30AMGlobeNewswire Inc.Theratechnologies Completes Enrollment of First Six Patients in Updated Phase 1 Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian CancerNASDAQ:THTXTheratechnologies Inc
02/06/20241:29PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
02/06/20246:30AMGlobeNewswire Inc.Theratechnologies to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide Business UpdateNASDAQ:THTXTheratechnologies Inc
02/01/202410:50AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
01/24/202412:52PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
01/24/20246:00AMGlobeNewswire Inc.Theratechnologies Receives Complete Response Letter (CRL) from the FDA for the F8 Formulation of Tesamorelin sBLANASDAQ:THTXTheratechnologies Inc
 Showing the most relevant articles for your search:NASDAQ:THTX

Your Recent History

BIT
P1WKW8
NLBNPIT1WKW8 20351221 32...
EU
FR2CIBFS3809
Credit Agricole CIB FCIA...
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved